Citius Oncology (CTOR) Research & Development (2023 - 2026)

Citius Oncology's Research & Development history runs 4 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Research & Development fell 65.62% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $4.1 million (down 40.27% YoY), while the FY2025 annual figure was $6.4 million, up 30.32% from the prior year.
• Research & Development was $1.1 million for Q1 2026 at Citius Oncology, up from $1.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $3.1 million in Q1 2025 to a low of $938277.0 in Q2 2025.
• Historically, Research & Development has averaged $1.3 million across 4 years, with a median of $1.1 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Research & Development soared 132.73% in 2025, then plunged 65.62% in 2026.
• A 4-year view of Research & Development shows it stood at $1.1 million in 2023, then climbed by 10.1% to $1.3 million in 2024, then fell by 19.47% to $1.0 million in 2025, then grew by 5.99% to $1.1 million in 2026.
• The last three Research & Development figures came in at $1.1 million (Q1 2026), $1.0 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.